Mutant myogenin promoter-controlled oncolytic adenovirus selectively kills PAX3-FOXO1-positive rhabdomyosarcoma cells

The PAX3-FOXO1 fusion gene functions as a transactivator and increases expression of many cancer-related genes. These lead to metastases and other unfavorable outcomes for alveolar rhabdomyosarcoma (ARMS) patients. In order to target ARMS with the PAX3-FOXO1 transactivator, we developed an Oncolytic...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Transl Oncol
Main Authors: Yoshida, Hideki, Sato-Dahlman, Mizuho, Hajeri, Praveensingh, Jacobsen, Kari, Koodie, Lisa, Yanagiba, Chikako, Shanley, Ryan, Yamamoto, Masato
Format: Artigo
Sprog:Inglês
Udgivet: Neoplasia Press 2020
Fag:
Original Research
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7749408/
https://ncbi.nlm.nih.gov/pubmed/33338875
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.tranon.2020.100997
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker